Genient Showcases Next-Gen Genomic Solutions at PMIC-2025, KGMU Lucknow

Genient Technologies marked a significant presence at the Precision Medicine and Intensive Care Conference – 2025 (PMIC-2025), held from 26th to 28th July at King George’s Medical University (KGMU), Lucknow. This high-profile international conference, organized by the Society of Precision Medicine and Intensive Care, brought together leading researchers, clinicians, innovators, and industry players to advance the integration of cutting-edge technologies in intensive care and personalized medicine.

Genient’s Participation: Driving Genomics into the ICU

At the heart of Genient’s exhibit was its suite of molecular diagnostic solutions tailored for critical care, with a particular focus on genomics-driven decision support, infectious disease diagnostics, and precision oncology panels. The company presented its latest innovations in real-time PCR assays, whole-genome sequencing tools, and point-of-care compatible technologies, aligning with the PMIC-2025 agenda of leveraging AI, Big Data, and Translational Genomics to improve ICU outcomes.

Speaking at the event, a spokesperson from Genient commented:

“Our mission at Genient is to make precision diagnostics more accessible, especially in acute care settings. PMIC-2025 has provided a powerful platform to showcase how genomics can directly impact patient management in ICUs—from sepsis and neurocritical care to maternal health and pharmacogenomics.”

Contributing to Collaborative Networks

Genient also engaged in discussions around several national initiatives launched at PMIC-2025, including the Personalized Genomics in Acute Care Consortium (PGACC) and the Precision Drug Monitoring & Pharmacogenomics Network (PDMPN). The company expressed interest in contributing to collaborative research, clinical validation studies, and development of next-gen genomic panels tailored for Indian ICU settings.

Conference Highlights

PMIC-2025 built upon the momentum of its 2024 edition, expanding its reach across key specialties such as:

• AI & Big Data in ICU care
• Genetics and personalized therapeutics
• Precision infection & sepsis management
• Pharmacokinetics and pharmacodynamics
• Neurocritical care and imaging biomarkers
• Maternal and neonatal intensive care

With the theme “A Strategic Pathway to Customizing Precision Medicine in Acute Care,” the event served as a confluence of clinical insight, emerging technologies, and translational research.

Looking Ahead

Genient’s active participation reflects its strategic commitment to pushing the boundaries of personalized medicine in critical care. With ongoing collaborations and continued product innovation, the company aims to contribute significantly to India’s growing ecosystem of precision healthcare.

As the call for integration of genomics, AI, and real-world clinical data grows louder, Genient is poised to play a pivotal role in transforming how acute care is delivered — one gene, one patient at a time.